10222 BARNES CANYON ROAD, BLDG. #2, SAN DIEGO, CA
Vertex to Acquire Pharmaceuticals
Election of Three Class II Directors at Crinetics Pharmaceuticals
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Chief Development Officer Resignation - Jeff Knight Steps Down
Jeff Knight Resigns as Chief Development and Operating Officer
Crinetics Pharmaceuticals Dismisses BDO as Independent Auditor
Financial Results, Press Release
Q1
FY 2024
Q3
Q2
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities